BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 33242559)

  • 1. EPB41 suppresses the Wnt/β-catenin signaling in non-small cell lung cancer by sponging ALDOC.
    Yuan J; Xing H; Li Y; Song Y; Zhang N; Xie M; Liu J; Xu Y; Shen Y; Wang B; Zhang L; Yang M
    Cancer Lett; 2021 Feb; 499():255-264. PubMed ID: 33242559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibulin-5 inhibits Wnt/β-catenin signaling in lung cancer.
    Chen X; Song X; Yue W; Chen D; Yu J; Yao Z; Zhang L
    Oncotarget; 2015 Jun; 6(17):15022-34. PubMed ID: 25909283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced expression of circular RNA hsa_circ_000984 promotes cells proliferation and metastasis in non-small cell lung cancer by modulating Wnt/β-catenin pathway.
    Li XY; Liu YR; Zhou JH; Li W; Guo HH; Ma HP
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3366-3374. PubMed ID: 31081091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA OSER1‑AS1 promotes the malignant properties of non‑small cell lung cancer by sponging microRNA‑433‑3p and thereby increasing Smad2 expression.
    Liu X; Huang S; Guan Y; Zhang Q
    Oncol Rep; 2020 Aug; 44(2):599-610. PubMed ID: 32627026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway.
    Cui Y; Zhang F; Zhu C; Geng L; Tian T; Liu H
    Oncotarget; 2017 Mar; 8(11):17785-17794. PubMed ID: 28147312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer.
    Ma K; Fan Y; Dong X; Dong D; Guo Y; Wei X; Ning J; Geng Q; Wang C; Hu Y; Li M; Niu W; Li E; Wu Y
    Oncotarget; 2017 Jun; 8(24):38825-38840. PubMed ID: 28418915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway.
    Wang Z; Luo Z; Zhou L; Li X; Jiang T; Fu E
    Cancer Sci; 2015 Oct; 106(10):1303-12. PubMed ID: 26212035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. microRNA-100 functions as a tumor suppressor in non-small cell lung cancer via regulating epithelial-mesenchymal transition and Wnt/β-catenin by targeting HOXA1.
    Han W; Ren X; Yang Y; Li H; Zhao L; Lin Z
    Thorac Cancer; 2020 Jun; 11(6):1679-1688. PubMed ID: 32364673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4.1N is involved in a flotillin-1/β-catenin/Wnt pathway and suppresses cell proliferation and migration in non-small cell lung cancer cell lines.
    Yang Q; Zhu M; Wang Z; Li H; Zhou W; Xiao X; Zhang B; Hu W; Liu J
    Tumour Biol; 2016 Sep; 37(9):12713-12723. PubMed ID: 27448302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of HJURP inhibits non-small cell lung cancer cell proliferation, migration, and invasion by repressing Wnt/β-catenin signaling.
    Wei Y; Ouyang GL; Yao WX; Zhu YJ; Li X; Huang LX; Yang XW; Jiang WJ
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3847-3856. PubMed ID: 31115012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astrocyte elevated gene-1(AEG-1) induces epithelial-mesenchymal transition in lung cancer through activating Wnt/β-catenin signaling.
    He W; He S; Wang Z; Shen H; Fang W; Zhang Y; Qian W; Lin M; Yuan J; Wang J; Huang W; Wang L; Ke Z
    BMC Cancer; 2015 Mar; 15():107. PubMed ID: 25880337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HBP1 promoter methylation augments the oncogenic β-catenin to correlate with prognosis in NSCLC.
    Tseng RC; Huang WR; Lin SF; Wu PC; Hsu HS; Wang YC
    J Cell Mol Med; 2014 Sep; 18(9):1752-61. PubMed ID: 24895061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOX9 drives the epithelial-mesenchymal transition in non-small-cell lung cancer through the Wnt/β-catenin pathway.
    Huang JQ; Wei FK; Xu XL; Ye SX; Song JW; Ding PK; Zhu J; Li HF; Luo XP; Gong H; Su L; Yang L; Gong LY
    J Transl Med; 2019 May; 17(1):143. PubMed ID: 31060551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miRNA-125b regulates apoptosis of human non-small cell lung cancer via the PI3K/Akt/GSK3β signaling pathway.
    Wang Y; Zhao M; Liu J; Sun Z; Ni J; Liu H
    Oncol Rep; 2017 Sep; 38(3):1715-1723. PubMed ID: 28713974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leucine zipper tumor suppressor 2 inhibits cell proliferation and regulates Lef/Tcf-dependent transcription through Akt/GSK3β signaling pathway in lung cancer.
    Cui QZ; Tang ZP; Zhang XP; Zhao HY; Dong QZ; Xu K; Wang EH
    J Histochem Cytochem; 2013 Sep; 61(9):659-70. PubMed ID: 23761130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ALDOC promotes non-small cell lung cancer through affecting MYC-mediated UBE2N transcription and regulating Wnt/β-catenin pathway.
    Shang B; Lu F; Jiang S; Xing M; Mao X; Yang G; Zhang H
    Aging (Albany NY); 2023 Sep; 15(18):9614-9632. PubMed ID: 37724906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of NEAT1 Suppresses Cell Proliferation, Migration, and Invasion in NSCLC Via Sponging miR-153-3p.
    Zhao L; Bi M; Zhang H; Shi M
    Cancer Biother Radiopharm; 2020 Jun; 35(5):362-370. PubMed ID: 32380843
    [No Abstract]   [Full Text] [Related]  

  • 18. The RNA-binding protein RBM47 inhibits non-small cell lung carcinoma metastasis through modulation of AXIN1 mRNA stability and Wnt/β-catentin signaling.
    Shen DJ; Jiang YH; Li JQ; Xu LW; Tao KY
    Surg Oncol; 2020 Sep; 34():31-39. PubMed ID: 32891348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleolar and spindle‑associated protein 1 promotes non‑small cell lung cancer progression and serves as an effector of myocyte enhancer factor 2D.
    Ling B; Wei P; Xiao J; Cen B; Wei H; Feng X; Ye G; Li S; Zhang Z; Liang W; Huang S; Huang W
    Oncol Rep; 2021 Mar; 45(3):1044-1058. PubMed ID: 33650655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulforaphane suppresses EMT and metastasis in human lung cancer through miR-616-5p-mediated GSK3β/β-catenin signaling pathways.
    Wang DX; Zou YJ; Zhuang XB; Chen SX; Lin Y; Li WL; Lin JJ; Lin ZQ
    Acta Pharmacol Sin; 2017 Feb; 38(2):241-251. PubMed ID: 27890917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.